For B2B procurement managers in the global veterinary industry—including veterinary oncology clinics, specialty pet hospitals, OEM/ODM manufacturers, and animal health distributors—providing science-backed nutritional support for pets with cancer has become a critical market priority. Cancer treatment (chemotherapy, radiation, surgery) in companion animals often leads to severe side effects: appetite loss, immune suppression, weight loss, and reduced quality of life. Yipai Biotechnology addresses this gap with the Cancer Treatment Support for Pets: a natural, clinical-strength supplement engineered to complement veterinary oncology care, combining Traditional Chinese Medicine (TCM) wisdom with cutting-edge biotechnology—designed to meet the rigorous standards of international B2B partners.
Unlike generic Pet Specialty Oral Vitamins, this formula is exclusively optimized for cancer-affected pets, integrating Yipai’s patented Reishi Mushroom With Vitamin A For Pets complex and advanced enzymolysis technology. It delivers dual-action support: immune modulation to combat cancer-related suppression and targeted nutrition to address treatment-induced deficiencies. For B2B buyers, it offers three non-negotiable advantages: clinical relevance (backed by patents and veterinary data), global quality certification, and seamless integration into oncology protocols—key drivers of trust and profitability in veterinary channels. Below, we break down the product’s technical strengths, application value, and B2B collaboration benefits.
Core Advantages for B2B Veterinary Procurement
1. Patented Reishi Mushroom & Vitamin A Complex (Patent No. 202110933638.0)
The formula features Yipai’s proprietary Reishi Mushroom with Vitamin A for Pets blend—protected by an invention patent. Ganoderma lucidum (Reishi) delivers powerful antioxidant and immune-modulating benefits, combating free radical damage from cancer and treatment. Vitamin A supports epithelial tissue repair and immune cell function, forming a Veterinary-Formulated Reishi Vitamin A Complex that outperforms single-ingredient alternatives. For B2B partners, the patent ensures market exclusivity and differentiation in the competitive Veterinary Oncology Supplements segment.
2. Advanced Enzymolysis Technology (90%+ Bioavailability)
Yipai’s fresh meat enzymolysis process breaks down proteins into small-molecule peptides and amino acids, ensuring maximum nutrient absorption—critical for pets with compromised digestive systems due to cancer or treatment. This technology ensures Therapeutic Vitamin A with Reishi for Pets reaches target tissues efficiently, reducing wasted nutrients and improving clinical outcomes. For procurement managers, high bioavailability translates to fewer customer complaints and stronger brand loyalty from veterinary clinics.
3. Dual-Action Formulation (TCM + Western Nutrition)
The supplement merges TCM theory (immune modulation via Reishi) with Western nutritional science (targeted vitamins and amino acids), addressing both the root causes of cancer-related decline and treatment side effects. As part of Yipai’s Clinical-Strength Pet Multivitamin series, it supports appetite, muscle mass retention, and immune function—key priorities for pets undergoing chemotherapy, radiation, or surgery. This dual action eliminates the need for multiple supplements, simplifying inventory management for B2B distributors.
4. Global Quality Certification & Safety Compliance
- Manufactured in an FDA-registered facility (Registration No. 13323196228) and ISO 9001:2015 certified, meeting EU/US standards for Veterinary Specialty Vitamin Supplements.
- Batch-by-batch testing for potency, purity, and heavy metals—eliminating supply chain risks for B2B partners serving veterinary oncology clinics.
- Zero artificial additives, flavors, or preservatives—compliant with the strict safety requirements of specialty pet healthcare.
Target Application Scenarios for Veterinary Oncology
The Cancer Treatment Support for Pets solves critical pain points across veterinary B2B segments, driving high-margin sales and customer loyalty. Key use cases:
Chemotherapy & Radiation Support
Our Canine cancer support supplements address appetite loss, immune suppression, and weight reduction in pets undergoing conventional treatments—critical for oncology clinics seeking to improve treatment tolerance.
Post-Surgical Recovery
Aids wound healing and muscle mass retention after tumor removal, supporting faster recovery and reducing post-operative complications—valued by surgical veterinary hospitals.
Palliative Care
Our Immune support for pets with cancer maintains quality of life in advanced stages, managing side effects and supporting vital organ function—essential for hospice and palliative care providers.
Integrative Oncology Programs
Incorporated into comprehensive cancer care protocols worldwide, complementing traditional treatments with evidence-based nutrition—appealing to holistic veterinary clinics.
Professional Dosage & Administration
Flexible dosing adapts to body weight and treatment stage. Administer directly, mixed with food, or via syringe (1-2 times daily, adjust based on veterinary recommendation):
| Pet Weight | Dose per Administration |
| 1-5kg | 3-5ml |
| 5-10kg | 5-8ml |
| ≥10kg | 8-12ml |
B2B Collaboration Benefits
1. OEM/ODM Customization for Oncology Brands
Yipai offers fully customizable solutions: private labeling (oncology clinic logos, packaging design), formula adjustments (e.g., flavor optimization for appetite-compromised pets), and dosage form modifications. Our R&D team (backed by 13 patented technologies) delivers custom products in 30-45 days, helping you launch exclusive cancer support lines in your market.
2. Stable Supply & Competitive Pricing
- MOQ: 500 units (standard); 1,000 units (OEM/ODM)—flexible for small clinics and large distributors.
- Scalable Production: 6 automated lines with 20,000 units/month capacity, ensuring on-time bulk delivery (critical for ongoing oncology treatments).
- Volume Discounts: 10-25% off for orders exceeding 5,000 units, maximizing profit margins for B2B partners.
3. Oncology-Specific Support & Resources
Receive veterinary oncology protocol guides, clinical trial reports, multilingual datasheets (English, German, Spanish), and 24/7 technical support from our veterinary oncology team. We also provide SEO-optimized content for your B2B website to drive leads in the specialty pet healthcare segment.
B2B Veterinary Partner FAQ
Q1: Is the product compliant with EU and US veterinary oncology standards?Yes. It meets EU Feed Additive Regulations (EC 1831/2003) and US FDA requirements for
Veterinary supplements. Full compliance documentation (certificates, test reports) is provided for customs clearance and veterinary registration.
Q2: Can we request a sample for clinical evaluation in our oncology clinic?Absolutely. We offer free clinical samples (up to 10 units) for veterinary oncology facilities, with shipping costs covered by Yipai. Samples include a detailed usage guide and clinical efficacy data from pilot studies.
Q3: What is the shelf life and storage requirement?Shelf life is 24 months from production (stored at 0-25℃). Airtight, light-resistant packaging ensures freshness, with clear batch/expiry dates for easy inventory management in veterinary clinics.
Q4: How does this product interact with conventional cancer treatments?The supplement is designed to complement chemotherapy, radiation, and surgery—no known adverse interactions. It supports treatment tolerance by reducing side effects (e.g., appetite loss, immune suppression) and enhancing recovery, as validated by veterinary oncology professionals.
Partner with Yipai for Veterinary Oncology Excellence
Yipai’s Cancer Treatment Support for Pets is a strategic B2B asset for veterinary oncology channels, combining clinical efficacy, natural ingredients, and scalability. It addresses an unmet need in pet cancer care, driving revenue for distributors and improving patient outcomes for clinics. With our OEM/ODM capabilities and oncology-specific support, we’re your trusted partner in expanding your specialty pet healthcare portfolio.
Contact our B2B veterinary sales team today to request clinical samples, discuss customization, or get a detailed quotation. Let’s elevate cancer care standards for pets worldwide!
